Long-term safety and antitumor activity in the phase 1-2 study of enzalutamide in pre- and post-docetaxel castration-resistant prostate cancer

Celestia S. Higano, Tomasz M. Beer, Mary Ellen Taplin, Eleni Efstathiou, Mohammad Hirmand, David Forer, Howard I. Scher

    Research output: Contribution to journalArticlepeer-review

    24 Scopus citations

    Fingerprint Dive into the research topics of 'Long-term safety and antitumor activity in the phase 1-2 study of enzalutamide in pre- and post-docetaxel castration-resistant prostate cancer'. Together they form a unique fingerprint.

    Medicine & Life Sciences